Ad Scientiam Announces a Critical Milestone Reached with the Enrollment of the First Patient In in the HARMONY 360 Study

Ad Scientiam, a pioneering MedTech company specialized in the development of digital biomarkers, today announced the enrollment of the First Patient In (FPI) in
Read the full report on Ein Presswire
Story file
- Section
- Business
- Topics
- Economy & RBI
- First reported by
- Ein Presswire
- Reporter
- loïc carment
- Published
- Thursday, 8 October 2026, 3:30 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Ein Presswire with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
